Delivery Order SPE2DR25D3103-SPE2DR26F9J47
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,653.85 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on September 25, 2025, with a ceiling value of $19,403.50. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 60 mg tablets (30-count units) under a firm fixed-price contract valued at $2,957.95. This non-competitive delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,377.96 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count package) under a firm fixed-price contract. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,295.43 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $50,064.71 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, issued on September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J47Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,075.80 for Latuda 120 mg tablets (30-count supply) on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply agreement running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical prime vendor within the federal medical supply chain, specifically supporting military and veteran healthcare systems through the DLA. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The SPE2DX IDC serves as a flexible contracting vehicle enabling the company to deliver a wide range of pharmaceutical products, vaccines, syringes, vials, and specialized medical supplies to support Defense Health Agency operations and other federal healthcare customers worldwide. Latuda, an atypical antipsychotic used primarily in psychiatric treatment, reflects the specialized neurological and psychiatric medications within AmerisourceBergen's federal supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/24/25 |